1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,300 | 2,800 | 16:37 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | ABL Diagnostics to Participate in the European Main MidCap Event Paris 2026 on September 30 and October 1, 2026 | 281 | Business Wire | Regulatory News:
ABL Diagnostics (Euronext Paris Compartment B ISIN: FR001400AHX6 ABLD), an international company specializing in molecular diagnostic solutions, healthcare software and life sciences... ► Artikel lesen | |
| ABL DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| Mo | ABL Diagnostics SA: ABL Diagnostics Announces Availability of the Latest All Invest Securities Research Report | 479 | Business Wire | Regulatory News:
ABL Diagnostics (Euronext Paris: ABLD ISIN: FR001400AHX6) (the "Company"), a company specializing in molecular diagnostic solutions, healthcare software and clinical research services... ► Artikel lesen | |
| Fr | ABL Diagnostics (ABLD) Announces the Filing of a Takeover Bid for Integragen | 433 | Business Wire | Regulatory News:
ABL Diagnostics (Euronext Paris: ABLD ISIN: FR001400AHX6) (the "Company"), a company specialized in molecular diagnostics solutions, healthcare software and services supporting... ► Artikel lesen | |
| 10.09. | ABIONYX Pharma Reaches Another Key Milestone in the Industrialization of CER-001 by Entering into a Strategic Partnership with TEXCELL (ABL Diagnostics) for the Viral Safety and Clearance of Biologics | 393 | Business Wire | Preparation of validation batches for the CER-001 bioproduction process based on viral safety studies A key step in the industrial and regulatory dossier toward a future market launch for... ► Artikel lesen | |
| 10.09. | ABL Diagnostics - TEXCELL Strengthens Its Position as an International Reference in Safety and Viral Clearance With a New Strategic Partnership With ABIONYX Pharma | 555 | Business Wire | • Selection of ABL Diagnostics' TEXCELL division for CER-001 viral safety and clearance studies • Support for a key stage of ABIONYX Pharma's industrial and regulatory program • Confirmation... ► Artikel lesen | |
| 08.09. | ABL Diagnostics Confirms Its Change of Scale in the First Half of 2026: Revenue up 90.0%, EBITDA Multiplied by More Than Four and Net Income up 343.3% Compared to the First Half of 2025 | 441 | Business Wire | In six months, ABL Diagnostics has already achieved 77.9% of 2025 annual sales and 29.7% higher than the net profit recorded for the full 2025 financial year Revenue of €5.415 million in H1... ► Artikel lesen | |
| 27.08. | ABL Diagnostics: Ordinary and Extraordinary General Meeting of September 17, 2026 - Arrangements for the Availability and Consultation of Preparatory Documents | 384 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) informs its shareholders that they are invited to attend an Ordinary and Extraordinary General Meeting to be held on Thursday, September 17, 2026,... ► Artikel lesen | |
| 27.08. | ABL Diagnostics: Information Relating to the Total Number of Voting Rights and the Number of Shares Constituting the Share Capital | 361 | Business Wire | (Articles L. 233-8, II of the French Commercial Code and 223-16 of the AMF General Regulation)
Regulatory News:
ABL Diagnostics: (Paris:ABLD)
Date Total Number of Shares... ► Artikel lesen | |
| 07.08. | ABL Diagnostics - Proposed Transfer of the Listing of Its Securities From the Regulated Market of Euronext Paris to Euronext Growth Paris | 842 | Business Wire | Regulatory News:
ABL Diagnostics (Euronext Paris: ABLD ISIN: FR001400AHX6) (the "Company"), an international company specializing in innovative molecular biology tests and global solutions for... ► Artikel lesen | |
| 29.07. | ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL | 436 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| 27.07. | ABL Diagnostics Announces Amendment to the Equity Line and Share Loan Agreement Between Its Main Shareholder ABL SA (Luxembourg) and Alumni Capital | 483 | Business Wire | Introduction of a minimum floor price of €4.50 per share for any future drawdown
Reduction of the maximum drawdown size from 50,000 to 2,500 shares
Immediate return of 98,026 loaned... ► Artikel lesen | |
| 23.07. | ABL Diagnostics acquires TEXCELL assets for €2.9 million | 3 | Investing.com | ||
| 23.07. | ABL Diagnostics Selected by the Évry Commercial Court to Acquire TEXCELL's Operations | 432 | Business Wire | Strengthening Life Sciences and Infectious Diseases Activities at Genopole, with Synergies in Virology, Biosafety, and Biological Control
Regulatory News:
ABL Diagnostics (Euronext Paris Compartment... ► Artikel lesen | |
| 22.07. | ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL | 365 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| 15.07. | ABL Diagnostics Informed that its Reference Shareholder ABL Has Crossed Below the 95% Threshold | 430 | Business Wire | Methodical continuation of the free float expansion strategy, in line with the commitments set forth in the 2022 Prospectus. Boosting stock liquidity and strengthening visibility among... ► Artikel lesen | |
| 10.07. | ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL | 367 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| 03.07. | Dividendenbekanntmachungen (03.07.2026) | 9.062 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABL DIAGNOSTICS SA FR001400AHX6 - 0,11 EUR AGORA SA PLAGORA00067 0,5 PLN 0,1165 EUR ALBIS LEASING AG DE0006569403 - 0,1 EUR BILIA... ► Artikel lesen | |
| 02.07. | ABL Diagnostics - Approval of Dividend Distribution for Fiscal Year 2025 | 627 | Business Wire | Regulatory News:
At the Annual General Meeting of ABL Diagnostics (Paris:ABLD) held on Tuesday, June 30, 2026, at 11:00 a.m., shareholders approved all resolutions submitted for their vote, including... ► Artikel lesen | |
| 18.06. | ABL Diagnostics: Growth Trajectory Confirmed and Strong Upside Potential Identified | 475 | Business Wire | Target price: €8.7 Recommendation: Buy
Regulatory News:
ABL DIAGNOSTICS (FR001400AHX6 ABLD-FR), a leading company in the field of molecular diagnostics and genotyping, announces the... ► Artikel lesen | |
| 12.06. | ABL Diagnostics and CDL Pharma Secure a Multi-year International Contract of up to €2.7 Million Through 2031 | 502 | Business Wire | Regulatory News:
ABL Diagnostics (FR001400AHX6 "ABLD") announces the signing of a multi-year contract with a European pharmaceutical company in the field of neurodegenerative diseases. The contract... ► Artikel lesen |
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 38,540 | +0,47 % | BERENBERG stuft Siemens Healthineers auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Siemens Healthineers mit einem Kursziel von 40 Euro auf "Hold" belassen. Der Medizintechnik- und Life-Science-Sektor bleibe fundamental attraktiv... ► Artikel lesen | |
| THERMO FISHER | 568,20 | +0,50 % | Dividendenbekanntmachungen (15.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AKVA GROUP ASA NO0003097503 1 NOK 0,0927 EUR ALEXANDRIA GROUP OYJ FI4000153465 - 0,35 EUR ALTRIA GROUP INC US02209S1033 1,11 USD 0... ► Artikel lesen | |
| STRATEC | 24,900 | 0,00 % | Stratec: Die Richtung stimmt - Charttechnik liefert Impulse | Unsere Medizintechnik-Empfehlung Stratec arbeitet am avisierten Turnarpound. Gut 15 % Wachstum bei Analysensystemn im ersten Halbjahr können sich sehen lassen. Das Geschäft mit Service-, Ersatzteilen... ► Artikel lesen | |
| UNIDOC HEALTH | 0,051 | -5,56 % | UniDoc Health Corp.: UniDoc Health Equips San Juan, Puerto Rico Ambulances With Live Patient Video | Upgraded E-PTZ Camera Integrates into UniDoc Connect for Full In-Transit Patient Coverage Across San Juan's Ambulance Fleet TORONTO, ON / ACCESS Newswire / September 17, 2026 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF)... ► Artikel lesen | |
| DIASORIN | 76,48 | +1,70 % | DiaSorin Reports Lower H1 Profit, Confirms FY26 Outlook | ROME (dpa-AFX) - DiaSorin S.p.A. (DIA.MI) on Friday, reported lower revenue and net profit for the first half of 2026, as higher operating expenses and weaker profitability offset growth recorded... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,170 | -2,15 % | EQS-PVR: Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG | EQS Stimmrechtsmitteilung: Fresenius Medical Care AG
Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG
10.09.2026... ► Artikel lesen | |
| FRESENIUS | 46,055 | -0,18 % | EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.09.2026 / 11:59... ► Artikel lesen | |
| AETHLON MEDICAL | 6,935 | +384,96 % | Morning Market Movers: AEMD, DAIC, LGVN, DLXY See Big Swings | OTTAWA (dpa-AFX) - At 8:50 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 9,090 | +4,36 % | Alignment Healthcare extends retreat, falls an additional 16% | ||
| BETA BIONICS | 21,960 | -0,99 % | Beta Bionics, Inc.: Beta Bionics Announces FDA Clearance of Mint, the Company's Transformative Patch Pump, and Unveils 3D Intelligence as its Next-Generation Insulin Dosing Algorithm | Mint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,80 | -0,27 % | Here's Why You Should Add BrightSpring Stock to Your Portfolio Now | ||
| GENEDX | 101,29 | +3,91 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| CARL ZEISS MEDITEC | 29,540 | -2,51 % | EQS-DD: Carl Zeiss Meditec AG: Andreas Pecher, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.09.2026 / 15:20... ► Artikel lesen | |
| ESSILORLUXOTTICA | 142,20 | -2,23 % | Wie kommt eine neue Brillentechnologie in einen 160-Milliarden-Dollar-Markt? Warum Vertrieb für kleine Health-Tech-Unternehmen zum entscheidenden Faktor wird | ||
| AVEANNA HEALTHCARE | 14,200 | -0,42 % | Aveanna Healthcare auf dem Deutsche Bank Healthcare Summit 2026: Neuausrichtung auf Wachstumskurs |
ABL DIAGNOSTICS SA gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 2,580 Euro. Beim derzeitigen Kurs ergibt sich, basierend auf einer gesamten Ausschüttung von 0,22 Euro in den vergangenen 12 Monaten, eine Dividendendrendite von +8,53 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ABL DIAGNOSTICS SA finden Sie auf Wallstreet Online.